One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
One-year treatment of obesity: randomized, double-blind, placebo-controlled, multicenter study of orlistat, a gastrointestinal lipase inhibitor